Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001348805 | SCV001543122 | uncertain significance | Peroxisome biogenesis disorder | 2022-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 517 of the PEX6 protein (p.Arg517Trp). This variant is present in population databases (rs754790139, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with PEX6-related conditions. ClinVar contains an entry for this variant (Variation ID: 1044547). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25". The tryptophan amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Centogene AG - |
RCV001810035 | SCV002059783 | uncertain significance | Heimler syndrome 2 | 2019-06-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001831146 | SCV002077311 | uncertain significance | Zellweger spectrum disorders | 2020-03-13 | no assertion criteria provided | clinical testing |